Literature DB >> 3964754

Androgen and estrogen receptors in fetal rhesus monkey brain and anterior pituitary.

S M Pomerantz, T O Fox, S A Sholl, C C Vito, R W Goy.   

Abstract

In this study, we sought to identify and characterize cytosolic androgen and estrogen receptors in the brain and anterior pituitary gland (AP) of fetal rhesus monkeys using the technique of DNA-cellulose chromatography. Cytosolic extracts were prepared from fetal monkey (days 135-162 of gestation) tissues including hypothalamus-preoptic area/amygdala (HPOA/AMG), cerebral cortex, and AP. Extracts were incubated with [3H]testosterone, [3H]5 alpha-dihydrotestosterone, or [3H] 17 beta-estradiol and applied to DNA-cellulose columns. [3H]Androgen- and [3H]estrogen-binding activities from cytosolic extracts adhered to DNA-cellulose. After elution with a linear salt gradient (10-500 mM NaCl) [3H]androgen-binding activity exhibited elution maxima between 130-150 mM NaCl, while [3H] estrogen-binding activity exhibited elution maxima between 200-220 mM NaCl. These elution patterns were similar in every region examined and were characteristic of putative androgen and estrogen receptors found in other vertebrate species. Additional experiments established the high affinity-low capacity nature of both androgen- and estrogen-binding activities, as well as their inhibition by known competitors of receptor binding. Estimates of binding activity at ligand concentrations that approximated saturation suggested that the concentration (moles specific bound per mg cytosolic protein) of both androgen and estrogen receptor were highest in the AP, intermediate in the HPOA/AMG, and lowest in the cerebral cortex. Comparisons of androgen- and estrogen-binding activities revealed that in the AP, apparent concentrations of the estrogen receptor exceeded those of androgen. Androgen and estrogen receptor concentrations were roughly equivalent in the HPOA/AMG, whereas, in the cerebral cortex, androgen receptor concentration was greater than estrogen. Collectively, these data demonstrate that in the fetal primate brain and AP, distinct androgen and estrogen receptors are present which might mediate the action of gonadal steroids on sexual differentiation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3964754     DOI: 10.1210/endo-116-1-83

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Ontogeny of androgen receptor expression in the ovine fetal central nervous system and pituitary.

Authors:  Charles E Wood; Maureen Keller-Wood
Journal:  Neurosci Lett       Date:  2008-05-08       Impact factor: 3.046

2.  Estrogen formation and binding in the cerebral cortex of the developing rhesus monkey.

Authors:  N J MacLusky; F Naftolin; P S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

3.  ADHD symptoms and use of anabolic androgenic steroids among male weightlifters.

Authors:  Emilie Kildal; Bjørnar Hassel; Astrid Bjørnebekk
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

4.  Impact of estradiol on gamma-aminobutyric acid- and glutamate-mediated calcium responses of fetal baboon (Papio anubis) hippocampal and cortical neurons.

Authors:  Joseph L Nuñez; Graham W Aberdeen; Eugene D Albrecht; Margaret M McCarthy
Journal:  Endocrinology       Date:  2008-08-14       Impact factor: 4.736

Review 5.  Steroid hormones and brain development: some guidelines for understanding actions of pseudohormones and other toxic agents.

Authors:  B S McEwen
Journal:  Environ Health Perspect       Date:  1987-10       Impact factor: 9.031

6.  Maternal and Fetal Pharmacokinetics of Oral Radiolabeled and Authentic Bisphenol A in the Rhesus Monkey.

Authors:  Catherine A VandeVoort; Roy R Gerona; Frederick S Vom Saal; Alice F Tarantal; Patricia A Hunt; Anne Hillenweck; Daniel Zalko
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

7.  Brain connectivity aberrations in anabolic-androgenic steroid users.

Authors:  Lars T Westlye; Tobias Kaufmann; Dag Alnæs; Ingunn R Hullstein; Astrid Bjørnebekk
Journal:  Neuroimage Clin       Date:  2016-11-17       Impact factor: 4.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.